Fashion
Microsoft touts US$500 million AI savings while slashing jobs
[ad_1] [NEW YORK] Microsoft is keen to show employees how much artificial intelligence (AI) is transforming its own workplace, even as the company terminates thousands of personnel.During a presentation this...
Europe: Shares close at four-week high on banks boost; US trade talks in focus
[ad_1] EUROPEAN shares closed at a four-week high on Wednesday, with banks the biggest boost as investors awaited signs of progress on a trade accord between the United States and...
US Fed minutes show committee split around inflation worries
[ad_1] [WASHINGTON] The emerging divide among US Federal Reserve officials over the outlook for interest rates is being driven largely by differing expectations for how tariffs might affect inflation, a...
US: Wall Street opens higher as markets await trade talks
[ad_1] Published Wed, Jul 9, 2025 · 09:48 PM[NEW YORK] Wall Street’s main indexes opened higher on Wednesday (Jul 9), as investors shrugged off President Donald Trump’s aggressive tariff moves...
SGX securities turnover up 23% in June, bringing financial year’s gain to 28%
[ad_1] [SINGAPORE] The operator of the local stock market reported gains in the trading value and volumes of its key products in June, which contributed to the Singapore Exchange (SGX)...
Australia’s Telstra to axe 550 roles in enterprise business overhaul
[ad_1] Published Wed, Jul 9, 2025 · 07:42 PM[SYDNEY] Telstra Group, Australia’s top telecom operator, said on Wednesday (Jul 9) that it plans to lay off 550 employees as part...
Contributor: The human brain doesn’t learn, think or recall like an AI. Embrace the difference
[ad_1] Recently, Nvidia founder Jensen Huang, whose company builds the chips powering today’s most advanced artificial intelligence systems, remarked: “The thing that’s really, really quite amazing is the way you...
Merck nears US$10 billion deal for London-based lung therapy firm Verona, FT reports
[ad_1] [LONDON] Merck is nearing a US$10 billion deal to buy lung diseases focussed Verona Pharma, as the US drugmaker is eyeing deals to offset the upcoming patent expiry of...